1. What is one reason healthcare stocks are often considered more resilient during economic downturns?
2. Why do medical device companies often benefit from long-term demographic trends?
3. What is a key advantage of healthcare companies with recurring revenue models?
4. Why might investors include both pharmaceutical and medical device stocks in a healthcare allocation?
5. Which factor is most important when evaluating higher-growth healthcare stocks?
